Page last updated: 2024-08-24

benidipine and Metabolic Syndrome

benidipine has been researched along with Metabolic Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Furuta, K; Hongo, M; Ishizaka, N; Koike, K; Matsuzaki, G; Nagai, R; Saito, K; Sakamoto, A; Sakurai, R	1
Araki, S; Fujii, T; Isshiki, K; Kanasaki, M; Kashiwagi, A; Kimura, G; Nishimura, M; Sakaguchi, M; Sugiomoto, T; Uzu, T	1
Furuta, K; Hongo, M; Ishizaka, N; Koike, K; Matsuzaki, G; Nagai, R; Saito, K; Sakurai, R	1

Trials

1 trial(s) available for benidipine and Metabolic Syndrome

Article	Year
Benidipine attenuates glomerular hypertension and reduces albuminuria in patients with metabolic syndrome. Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:2 Topics: Albuminuria; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension, Renal; Kidney Glomerulus; Male; Metabolic Syndrome; Middle Aged; Renal Circulation; Treatment Outcome	2007

Article

Year

Benidipine attenuates glomerular hypertension and reduces albuminuria in patients with metabolic syndrome.

Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:2

Topics: Albuminuria; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension, Renal; Kidney Glomerulus; Male; Metabolic Syndrome; Middle Aged; Renal Circulation; Treatment Outcome

2007

Other Studies

2 other study(ies) available for benidipine and Metabolic Syndrome

Article	Year
Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome. Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:3 Topics: AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Channel Blockers; Carnitine O-Palmitoyltransferase; Cholesterol; Dihydropyridines; Disease Models, Animal; Kidney; Lipid Metabolism; Losartan; Male; Metabolic Syndrome; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Superoxides; Triglycerides	2010
Comparison of vasculoprotective effects of benidipine and losartan in a rat model of metabolic syndrome. European journal of pharmacology, 2008, Jun-10, Volume: 587, Issue:1-3 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Calcium Channel Blockers; Dihydropyridines; Endothelium, Vascular; Fibrosis; Heart; In Vitro Techniques; Losartan; Metabolic Syndrome; Muscle Relaxation; Myocardium; Nitrates; Nitrites; Rats; Rats, Inbred OLETF; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2008

Article

Year

Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome.

Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:3

Topics: AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Channel Blockers; Carnitine O-Palmitoyltransferase; Cholesterol; Dihydropyridines; Disease Models, Animal; Kidney; Lipid Metabolism; Losartan; Male; Metabolic Syndrome; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Superoxides; Triglycerides

2010

Comparison of vasculoprotective effects of benidipine and losartan in a rat model of metabolic syndrome.

European journal of pharmacology, 2008, Jun-10, Volume: 587, Issue:1-3

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Calcium Channel Blockers; Dihydropyridines; Endothelium, Vascular; Fibrosis; Heart; In Vitro Techniques; Losartan; Metabolic Syndrome; Muscle Relaxation; Myocardium; Nitrates; Nitrites; Rats; Rats, Inbred OLETF; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2008